为解决平衡感分子机制未完全明晰的问题，山东大学研究人员开展关于平衡感相关受体的研究。发现力敏感 GPCR——LPHN2 对维持正常平衡至关重要。该研究为理解平衡感及治疗眩晕等疾病提供新思路，值得科研读者一读。

在动荡的市场环境下，Structure Therapeutics ADR（股票代码：GPCR）股价跌至52周新低，触及23.48美元。根据 InvestingPro 数据显示，该股从52周高点62.74美元大幅下跌，分析师给出的目标价区间为50美元至118美元。这一显著跌势反映了投资者普遍谨慎的态度，因为该公司正在应对制药板块面临的诸多挑战。过去一年，GPCR的市值大幅缩水，一年跌幅达48.58% ...

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. A mere six months ago Verily ...

Both live webcasts can also be accessed under “Events & Presentations” on the Investors section of the Tectonic website at www.tectonictx.com. Once these conferences have concluded, a replay of the ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in two upcoming ...

Trial decision follows unanticipated events of elevated unconjugated bilirubin levels Company advancing multiple next-generation PTH1R agonists with distinct and unrelated chemical structures relative ...

Septerna discontinues phase 1 clinical trial of SEP-786; plans to advance next-generation oral small molecule PTH1R agonist: South San Francisco, California Friday, February 21, 2 ...

Septerna stood out from the crowd of biotech IPOs last year due to the lack of clinical data to hand. Now, the data are ...

为探究 ET-1 对卵巢癌相关细胞外基质（ECM）蛋白的调控作用，研究人员开展 ET-1 在卵巢癌中作用的研究。结果发现 ET-1 影响 Col1 和 FN 表达，且高相关基因表达与患者预后不良有关。推荐阅读，助您了解卵巢癌研究新进展。